...

首页> 外文期刊>Gastrointestinal Cancer Research >On the State of the Art of Adjuvant Chemotherapy for Colon Cancer

【24h】

On the State of the Art of Adjuvant Chemotherapy for Colon Cancer

机译：关于结肠癌辅助化疗的技术现状

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Gastrointestinal Cancer Research》 |2007年第3期|共3页
作者
Bert O’Neil; Richard M. Goldberg;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). [J] . Di Costanzo F, Sobrero A, Gasperoni S, Annals of oncology: official journal of the European Society for Medical Oncology . 2003,第9期

机译：结肠癌辅助化疗：意大利国家结肠癌辅助化疗联合小组（INTACC）的随机多中心试验。
2. Putting a Lid on Chemotherapy Costs: Genomic Health's Oncotype DX Colon Cancer Assay assesses the risk of stage II colon cancer recurrence and potential adjuvant chemotherapy benefit. Cost savings could be huge. [J] . BOB CARLSON, MHA Biotechnology healthcare . 2011,第2期

机译：降低化学疗法的成本：Genomic Health的Oncotype DX结肠癌分析法评估了II期结肠癌复发的风险和辅助化疗的潜在益处。节省成本可能是巨大的。
3. Comparison of adjuvant FOLFOX4 chemotherapy and oral UFUR/LV following adjuvant FOLFOX4 chemotherapy in patients with stage III colon cancer subsequent to radical resection [J] . Huang Ming-Yii, Huang Chun-Ming, Tsai Hsiang-Lin, Oncology letters . 2017,第6aPta2期

机译：佐剂Folfox4化疗和口服UFUR / LV对辅助FOLFOX4化疗后III阶段结肠癌患者的比较
4. Adjuvant Chemotherapy Should Not Routinely Be Recommended to Patients with Stage II Colon Cancers that Manifest Microsatellite Instability [C] . Sigurdis Haraldsdottir, Richard M. Goldberg Gastrointestinal Cancers Symposium . 2014

机译：不应常规向患有阶段结肠癌的患者常规的辅助化学疗法，表明微卫星不稳定性
5. Adherence to adjuvant chemotherapy and post-treatment surveillance in a large community-based cohort of patients with colon cancer. [D] . Hu, Chung-Yuan. 2010

机译：在结肠癌患者的大型社区队列中坚持辅助化疗和治疗后监测。
6. Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set [O] . Joleen Hubbard, David M. Thomas, Greg Yothers, -1

机译：结肠癌辅助化疗的年轻患者和老年患者的获益和不良事件：佐剂结肠癌终点数据集的发现
7. Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project [O] . J. Souglakos, I. Boukovinas, S. Kakolyris, 2019

机译：六个月的六个月佐剂Folfox或Capox用于高风险阶段II和III阶段结肠癌患者：Hellenic肿瘤研究组（Horg）参与佐剂化疗的国际持续时间评估（IDEA）项目的疗效结果

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号